Tiziana Life Sciences PLC: Peer reviewed scientific article underscores the potential of monoclonal antibody nasal spray as a take-home Covid treatment

The update comes ahead of the imminent launch of a phase II, proof-of-concept study of Foralumab

Related Keywords

Brazil ,Kunwar Shailubhai ,Howard Weiner , ,Pharma Biotech ,Tiziana Life Sciences Plc ,Lon Tils ,Roactiveinvestors ,பிரேசில் ,ஹோவர்ட் வீனர் ,பார்மா பயோடெக் ,